Evolving Industry Partnerships and Investments in Cell and Gene Therapies.
Cell Stem Cell
; 22(5): 623-626, 2018 05 03.
Article
in En
| MEDLINE
| ID: mdl-29656942
Cell and gene therapies hold the promise of providing significant and durable health gains to patients in many disease states and have recently elicited significant investor and partner interest. We cover the current state of industry partnerships and investments, highlight what makes a partnership advantageous, and discuss implications for stem cell therapies.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Stem Cells
/
Genetic Therapy
/
Cell- and Tissue-Based Therapy
Limits:
Animals
/
Humans
Language:
En
Journal:
Cell Stem Cell
Year:
2018
Document type:
Article
Country of publication:
United States